English | Hindi | Spanish | Deutch
+91-11-23370009hsg@ima-india.org

Drug Safety Alert May 2016


Drug Safety Alert

The preliminary analysis of SUSARs from the PvPI database reveals that the following drugs are associated with the risks as given below.

Table

 

S.No

Suspected Drugs

Indication

Adverse Reactions

1

Peginterferon alpha-2a

Chronic active Hepatitis B & C

Vasculitis

2

Piperacillin & Tazobacam

In the treatment of lower RTI/UTI/intra abdominal infections, skin and skin structure infections, bacterial septicaemia polymicrobic infection

Vision abnormal

3

Mometasone Furoate, Topical

Steroid responsive dermatitis , eczema, or atopic dermatitis

Hypertrichosis/Hirsutism, Skin depigmentation

Health care professionals, Patients/Consumers are advised to closely monitor the possibility of the above adverse events while prescribing/consuming above suspected drugs and report to the NCC-PvPI either by filling of Suspected Adverse Drug Reactions Reporting Form/
Medicines Side Effect Reporting Form for Consumer (http://www.ipc.gov.in) or by PvPI Helpline No. 1800-180-3024.